Novel Semicarbazide-Sensitive Amine Oxidase Inhibitor Screening from Anti-Obesity Drugs Using HPLC-MS Based Technique

车宝泉,王琳,张永谦,肖盛元,邓玉林
DOI: https://doi.org/10.15918/j.jbit1004-0579.2013.01.013
2013-01-01
Journal of Beijing Institute of Technology
Abstract:Semicarbazide-sensitive amine oxidase ( SSAO) has been considered to be associated with the metabolism of glucose and fat,and elevated SSAO activity was observed in obese patients. In the present study,an in vitro SSAO activity-based method was developed to screen inhibitors from 1 5 anti-obesity drugs. Among the fifteen anti-obesity drugs,four drugs including caffeine,fenfluramine, bumetanide and amfebutamone inhibited SSAO activity,and caffeine was the most effective one. When the concentration of caffeine was 1 . 4 mmol / L,the inhibition ratio was 3 1 . 9 % and 1 8 . 8 % in rabbit serum and rat adipose tissue,respectively. Inhibition of SSAO activity by caffeine was also confirmed in the in vivo study,showing the inhibition ratio of 1 5 . 6 % on serum SSAO. Caffeine provides a natural source of inhibition of SSAO activity and may be a promising inhibitor for the study of SSAO.
What problem does this paper attempt to address?